Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep539 | Diabetes therapy | ECE2016

Patients’ understanding of hypoglycaemia in tertiary referral centers

Kim Mi-Kyung , Kim Nam Kyeong , Kim Eui Hyun , Park Keun-Gyu , Kim Hye-soon

Objective: Hypoglycemia is a common adverse event and one of the main obstacles to achieving good glycemic control to minimize the risk of diabetic complications in patients with diabetes. Therefore, most physicians try to reduce hypoglycemia events through education about hypoglycaemia, such as diabetes self-management education. In this study, we surveyed the actual insight about hypoglycemia, behavior of diabetic patients to avoid hypoglycemia and the fear of hypoglycemia.<...

ea0056p429 | Diabetes complications | ECE2018

The relationship between intertemporal choice and blood glucose control in type 2 diabetes

Lee Hyun Ju , Kim Mi-Kyung , Kim Yang Tae , Kim Hye soon , Cho Nan Hee

The objectives of this study were to investigate intertemporal choice in patients with type 2 Diabetes and whether blood glucose control is related to intertemporal choice. Ninety seven diabetes patients (41 inpatients and 56 outpatients) were recruited. All patients were subjected to the following tests: DM Distress Scale (DDS), Beck Anxiety Inventory (BAI), the Center for Epidemiologic Studies Depression Scale (CES-D) and the Big Five Inventory-K-10 (BFI-K-10). 73 of recruit...

ea0049ep506 | Diabetes complications | ECE2017

A protective effect of lobeglitazone on renal fibrosis in unilateral ureteral obstruction mice model

Kim Hye-Soon , Bae Kwi Hyun , Jung Gwon Soo , Ham Hye Jin , Park Bo Yoon , Choi Yeon Kyung , Seo hyun Ae , Seo Jung Beom , Park Keun Gyu

Renal tubulointerstitial fibrosis is a common feature of the final stage of nearly all cause types of chronic kidney disease. Although classic peroxisome proliferator-activated receptor-gamma (PPARĪ³) agonists have a protective effect on diabetic nephropathy, much less is known about their direct effects in renal fibrosis. This study aimed to investigate possible beneficial effects of lobeglitazone, a novel PPARĪ³ agonist, on renal fibrosis in mice with unilateral uret...

ea0041ep435 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Relation between uric acid and lipid profiles in patients with type 2 diabetes

Kim Eui-Hyun , Bae Kwi-Hyun , Jeon Jae-Han , Choi Yeon-Kyung , Kim Mi-Kyung , Kim Hye-Soon , Park Keun-Gyu , Seo Hyun-Ae

Aims: High level of uric acid is known to associate with stroke, coronary artery disease and metabolic syndrome. Some epidemiologic studies suggested that high uric acid level is connected with dyslipidemia. However, this relationship was not examined in type 2 diabetic patients. This study was conducted to investigate the association between serum uric acid level and lipid profiles in type 2 diabetic patients.Methods: A total of 972 type 2 diabetes pati...